 <h1>Epoetin alfa Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of epoetin alfa include:</b> upper respiratory tract infection, arthralgia, decreased serum iron, diarrhea, edema, fever, low serum ferritin, paresthesia, respiratory congestion, skin rash, tachycardia, cough, dyspnea, headache, nausea, signs and symptoms of injection site, and vomiting. <b>Other side effects include:</b> chest pain.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to epoetin alfa: injection solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Injection route (Solution)</p><p>ESAs increase the risk of death, myocardial infarction, stroke, venous thromboembolism, thrombosis of vascular access, and tumor progression or recurrence.Chronic Kidney Disease:In controlled trials, patients experienced greater risks for death, serious adverse cardiovascular reactions, and stroke when administered erythropoiesis-stimulating agents (ESAs) to target a hemoglobin level greater than 11 g/dL.No trial has identified a hemoglobin target level, ESA dose, or dosing strategy that does not increase these risks.Use the lowest epoetin alfa-epbx dose sufficient to reduce the need for red blood cell (RBC) transfusions.Cancer:ESAs shortened overall survival and/or increased the risk of tumor progression or recurrence in clinical studies of patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers.To decrease these risks, as well as the risk of serious cardiovascular and thromboembolic reactions, use the lowest dose needed to avoid RBC transfusions.Use ESAs only for anemia from myelosuppressive chemotherapy.ESAs are not indicated for patients receiving myelosuppressive chemotherapy when the anticipated outcome is cure.Discontinue following the completion of a chemotherapy course.Perisurgery:Due to increased risk of deep venous thrombosis (DVT), DVT prophylaxis is recommended.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, epoetin alfa may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking epoetin alfa:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>blurred vision</li>
<li>body aches or pain</li>
<li>bone pain</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>ear congestion</li>
<li>fever</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>itching, skin rash</li>
<li>loss of voice</li>
<li>nausea</li>
<li>nervousness</li>
<li>pain, redness, or swelling in the arm or leg</li>
<li>painful or difficult urination</li>
<li>pounding in the ears</li>
<li>runny or stuffy nose</li>
<li>slow or fast heartbeat</li>
<li>sneezing</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stomach pain</li>
<li>swollen glands</li>
<li>tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area</li>
<li>trouble breathing</li>
<li>unexplained weight loss</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>decreased urine</li>
<li>difficulty swallowing</li>
<li>fainting</li>
<li>irregular heartbeat</li>
<li>loss of appetite</li>
<li>mood changes</li>
<li>muscle pain or cramps</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>seizures</li>
<li>swelling</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>dark urine</li>
<li>diarrhea</li>
<li>fluid-filled skin blisters</li>
<li>hives</li>
<li>joint pain</li>
<li>light-colored stools</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>sensitivity to the sun</li>
<li>skin thinness</li>
<li>tightness in the chest</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of epoetin alfa may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Decreased weight</li>
<li>difficulty in moving</li>
<li>injection site irritation or pain</li>
<li>muscle spasm or stiffness</li>
<li>swelling or inflammation of the mouth</li>
<li>swollen joints</li>
<li>trouble sleeping</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Discouragement</li>
<li>feeling sad or empty</li>
<li>irritability</li>
<li>loss of interest or pleasure</li>
<li>trouble concentrating</li>
</ul><p>
<!-- end injection solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to epoetin alfa: injectable solution</i></p><h3>General</h3><p>The most common adverse reaction was dose-dependent increase in blood pressure or aggravation of existing hypertension.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 56%), diarrhea (up to 30%), vomiting (up to 28%), stomatitis (10%)</p>
<p><b>Common</b> (1% to 10%): Dysphagia</p>
<p><b>Frequency not reported</b>: Vomiting<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pyrexia (up to 42%)</p>
<p><b>Common</b> (1% to 10%): Chills, influenza-like illness, peripheral edema, artificial kidney clotting during dialysis, edema<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 34%)</p>
<p><b>Common</b> (1% to 10%): Convulsion, dizziness</p>
<p><b>Frequency not reported</b>: Cerebrovascular accident, transient ischemic attack<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (up to 33%), embolism and thrombosis (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Deep vein thrombosis, thrombosis</p>
<p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction</p>
<p><b>Frequency not reported</b>: Blood pressure increased, aneurysm<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (up to 26%)</p>
<p><b>Common</b> (1% to 10%): Respiratory tract congestion, upper respiratory tract infection, pulmonary embolism<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (up to 25%), pruritus (up to 21%)</p>
<p><b>Common</b> (1% to 10%): Urticaria</p>
<p><b>Uncommon</b> (0.1% to 1%): Erythema</p>
<p><b>Frequency not reported</b>: Angioedema</p>
<p><b>Postmarketing reports</b>: Severe cutaneous reactions<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (up to 24%), pain in extremity (up to 15%), myalgia (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Bone pain, muscle spasm</p>
<p><b>Frequency not reported</b>: Porphyria<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reaction (up to 18%), injection site pain (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Vascular access thrombosis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperkalemia (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Weight decrease, hyperglycemia, hypokalemia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, depression<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Leukopenia</p>
<p><b>Postmarketing reports</b>: Erythropoietin antibody-mediated pure red cell aplasia, thrombocytopenia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Anaphylactic reaction, hypersensitivity</p>
<p><b>Postmarketing reports</b>: Serious allergic reaction<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Epogen (epoetin alfa)." Amgen, Thousand Oaks, CA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. Procrit (epoetin alfa)." Ortho Biotech Inc, Raritan, NJ. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>How many biosimilars have been approved in the United States?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about epoetin alfa</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>9 Reviews</li>
<li>Drug class: recombinant human erythropoietins</li>
<li>FDA Alerts (7)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Epoetin alfa Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Epoetin alfa-epbx Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Procrit, Retacrit, Epogen</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Anemia Associated with Chronic Renal Failure</li>
<li>Anemia</li>
<li>Anemia, Chemotherapy Induced</li>
<li>Anemia Prior to Surgery</li>
<li>Anemia, Drug Induced</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to epoetin alfa: injectable solution</i></p><h3>General</h3><p>The most common adverse reaction was dose-dependent increase in blood pressure or aggravation of existing hypertension.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 56%), diarrhea (up to 30%), vomiting (up to 28%), stomatitis (10%)</p><p><b>Common</b> (1% to 10%): Dysphagia</p><p><b>Frequency not reported</b>: Vomiting<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pyrexia (up to 42%)</p><p><b>Common</b> (1% to 10%): Chills, influenza-like illness, peripheral edema, artificial kidney clotting during dialysis, edema<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 34%)</p><p><b>Common</b> (1% to 10%): Convulsion, dizziness</p><p><b>Frequency not reported</b>: Cerebrovascular accident, transient ischemic attack<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (up to 33%), embolism and thrombosis (up to 15%)</p><p><b>Common</b> (1% to 10%): Deep vein thrombosis, thrombosis</p><p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction</p><p><b>Frequency not reported</b>: Blood pressure increased, aneurysm<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (up to 26%)</p><p><b>Common</b> (1% to 10%): Respiratory tract congestion, upper respiratory tract infection, pulmonary embolism<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (up to 25%), pruritus (up to 21%)</p><p><b>Common</b> (1% to 10%): Urticaria</p><p><b>Uncommon</b> (0.1% to 1%): Erythema</p><p><b>Frequency not reported</b>: Angioedema</p><p><b>Postmarketing reports</b>: Severe cutaneous reactions<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (up to 24%), pain in extremity (up to 15%), myalgia (up to 10%)</p><p><b>Common</b> (1% to 10%): Bone pain, muscle spasm</p><p><b>Frequency not reported</b>: Porphyria<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reaction (up to 18%), injection site pain (up to 13%)</p><p><b>Common</b> (1% to 10%): Vascular access thrombosis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperkalemia (up to 10%)</p><p><b>Common</b> (1% to 10%): Weight decrease, hyperglycemia, hypokalemia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, depression<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Leukopenia</p><p><b>Postmarketing reports</b>: Erythropoietin antibody-mediated pure red cell aplasia, thrombocytopenia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Anaphylactic reaction, hypersensitivity</p><p><b>Postmarketing reports</b>: Serious allergic reaction<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Epogen (epoetin alfa)." Amgen, Thousand Oaks, CA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. Procrit (epoetin alfa)." Ortho Biotech Inc, Raritan, NJ. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>How many biosimilars have been approved in the United States?</li>
</ul><h2>More about epoetin alfa</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>9 Reviews</li>
<li>Drug class: recombinant human erythropoietins</li>
<li>FDA Alerts (7)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Epoetin alfa Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Epoetin alfa-epbx Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Anemia Associated with Chronic Renal Failure</li>
<li>Anemia</li>
<li>Anemia, Chemotherapy Induced</li>
<li>Anemia Prior to Surgery</li>
<li>Anemia, Drug Induced</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>